全文获取类型
收费全文 | 2401篇 |
免费 | 239篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 35篇 |
儿科学 | 68篇 |
妇产科学 | 20篇 |
基础医学 | 306篇 |
口腔科学 | 30篇 |
临床医学 | 304篇 |
内科学 | 511篇 |
皮肤病学 | 27篇 |
神经病学 | 216篇 |
特种医学 | 138篇 |
外科学 | 255篇 |
综合类 | 39篇 |
预防医学 | 289篇 |
眼科学 | 23篇 |
药学 | 162篇 |
中国医学 | 8篇 |
肿瘤学 | 216篇 |
出版年
2022年 | 16篇 |
2021年 | 27篇 |
2020年 | 38篇 |
2019年 | 46篇 |
2018年 | 54篇 |
2017年 | 44篇 |
2016年 | 45篇 |
2015年 | 49篇 |
2014年 | 52篇 |
2013年 | 75篇 |
2012年 | 87篇 |
2011年 | 111篇 |
2010年 | 62篇 |
2009年 | 64篇 |
2008年 | 77篇 |
2007年 | 93篇 |
2006年 | 100篇 |
2005年 | 79篇 |
2004年 | 87篇 |
2003年 | 79篇 |
2002年 | 77篇 |
2001年 | 68篇 |
2000年 | 83篇 |
1999年 | 60篇 |
1998年 | 30篇 |
1997年 | 33篇 |
1996年 | 33篇 |
1995年 | 24篇 |
1994年 | 45篇 |
1993年 | 32篇 |
1992年 | 43篇 |
1991年 | 62篇 |
1990年 | 47篇 |
1989年 | 69篇 |
1988年 | 51篇 |
1987年 | 58篇 |
1986年 | 44篇 |
1985年 | 38篇 |
1984年 | 37篇 |
1983年 | 38篇 |
1982年 | 17篇 |
1981年 | 20篇 |
1979年 | 39篇 |
1978年 | 39篇 |
1977年 | 30篇 |
1976年 | 29篇 |
1975年 | 20篇 |
1973年 | 21篇 |
1972年 | 20篇 |
1969年 | 20篇 |
排序方式: 共有2647条查询结果,搜索用时 15 毫秒
131.
Carotid stenosis is the most frequently factor involved in stroke. The diagnosis of these lesions in routinely based on ultrasonic examination which allows to detect the carotid stenoses which were essentially atheromatous. B-mode evaluates the fine echostructure of plaques and Doppler helps to quantify the degree of stenosis using direct and indirect hemodynamic criteria. Echography with the help of color Doppler imaging identifies the site of stenosis in order to determine the degree of stenosis as a percentage of normal carotid area. Moreover echography is an essential method to appreciate the surface as well as the echostructure of the carotid lesion which have to be taking into account for a well-adapted therapy. The maximal velocities determined at the tight site of the lesion, the spectral changes downstream the stenosis and the hemodynamic changes observed upstream and downsteam of the carotid stenosis allow a precise quantification of this stenosis. The information obtained using sonographic methods (including 2 direct hemodynamic criteria, 2 indirect hemodynamic criteria and, if possible, a B-mode assessment of the area) are essential to appreciate the neurological risk in these patients. 相似文献
132.
Davidson M Harvey PD Vervarcke J Gagiano CA De Hooge JD Bray G Dose M Barak Y Haushofer M 《International journal of geriatric psychiatry》2000,15(6):506-514
RATIONALE: Studies have shown that risperidone is safe and efficacious in young and middle-aged adults with chronic schizophrenia, but considerably fewer data are available on the treatment of elderly patients with schizophrenia or other psychotic disorders, particularly long-term outcomes. OBJECTIVE: A 12-month, open-label study was conducted to assess the effects of risperidone in elderly, chronically ill, psychotic patients. METHODS: This study enrolled 180 elderly, chronically ill, psychotic patients (median age, 72 years [range 54-89]), 97 of whom completed the 12-month study. At endpoint, the mean dose of risperidone was 3.7 mg/day. RESULTS: Clinical improvement (> or =20% reduction in Positive and Negative Syndrome Score [PANSS] total score) was achieved by 54% of patients at endpoint. There were significant reductions in PANSS total, subscale (positive, negative, and general psychopathology), and cognition cluster scores at endpoint (p<0.001). Clinical Global Impressions severity of illness scores showed continued improvement through month 12 (p<0.001). In contrast, PANSS data from a historical comparable control group of patients receiving conventional antipsychotic agents showed no symptom improvement over a 12-month treatment period. The severity of preexisting extrapyramidal symptoms (EPS) in patients treated with risperidone decreased significantly from baseline to endpoint (p<0.001), and the use of antiparkinsonian medication decreased from 41.1% of patients before the trial to 25.6% during the trial. There were no spontaneous reports of tardive dyskinesia (TD) and the incidence of assessed TD was 4.3% in contrast to the expected 26% reported in middle-aged and elderly patients receiving conventional antipsychotic agents for 1 year. CONCLUSIONS: Long-term treatment with risperidone was associated with continued symptom improvement, a decrease in the severity of preexising EPS, and a low incidence of TD in elderly psychotic patients. 相似文献
133.
Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. 总被引:25,自引:0,他引:25
Paola Pisani Freddie Bray D Maxwell Parkin 《International journal of cancer. Journal international du cancer》2002,97(1):72-81
In health services planning, in addition to the basic measures of disease occurrence incidence and mortality, other indexes expressing the demand of care are also required to develop strategies for service provision. One of these is prevalence of the disease, which measures the absolute number, and relative proportion in the population, of individuals affected by the disease and that require some form of medical attention. For most cancer sites, cases surviving 5 years from diagnosis experience thereafter the same survival as the general population, so most of the workload is therefore due to medical acts within these first 5 years. This article reports world-wide estimates of 1-, 2-3- and 4-5-year point prevalence in 1990 in the population aged 15 years or over, and hence describes the number of cancer cases diagnosed between 1986 and 1990 who were still alive at the end of 1990. These estimates of prevalence at 1, 2-3 and 4-5 years are applicable to the evaluation of initial treatment, clinical follow-up and point of cure, respectively, for the majority of cancers. We describe the computational procedure and data sources utilised to obtain these figures and compare them with data published by 2 cancer registries. The highest prevalence of cancer is in North America with 1.5% of the population affected and diagnosed in the previous 5 years (about 0.5% of the population in years 4-5 and 2-3 of follow-up and 0.4% within the first year of diagnosis). This corresponds to over 3.2 million individuals. Western Europe and Australia and New Zealand show very similar percentages with 1.2% and 1.1% of the population affected (about 3.9 and 0.2 million cases respectively). Japan and Eastern Europe form the next batch with 1.0% and 0.7%, followed by Latin America and the Caribbean (overall prevalence of 0.4%), and all remaining regions are around 0.2%. Cancer prevalence in developed countries is very similar in men and women, 1.1% of the sex-specific population, while in developing countries the prevalence is some 25% greater in women than men, reflecting a preponderance of cancer sites with poor survival such as liver, oesophagus and stomach in males. The magnitude of disease incidence is the primary determinant of crude prevalence of cases diagnosed within 1 year so that differences by region mainly reflect variation in risk. In the long-term period however different demographic patterns with long-life expectancy in high-income countries determine a higher prevalence in these areas even for relatively uncommon cancer sites such as the cervix. 相似文献
134.
135.
136.
Langat virus (LGT), a tick-borne flavivirus, is naturally attenuated for humans but it is very virulent in SCID mice. In contrast, viable recombinant chimeras of LGT (preM and E genes) and dengue type 4 virus (all other sequences) recovered in mosquito cell culture were completely attenuated in SCID mice but still capable of providing protection against LGT. To develop the chimeras into vaccine candidates, we adapted them to replicate efficiently in simian Vero cells, a satisfactory substrate for human vaccines. The adapted chimeras remained completely attenuated for SCID mice and, significantly, provided protection in immunocompetent mice against tick-borne encephalitis virus, the most virulent of the tick-borne flaviviruses. 相似文献
137.
138.
Kroese ED; Dortant PM; van Steeg H; van Oostrom CT; van der Houven van Oordt CW; van Kranen HJ; de Vries A; Wester PW; van Kreijl CF 《Carcinogenesis》1997,18(5):975-980
E mu-pim-1 transgenic mice are predisposed to develop lymphomas. Due to
their low spontaneous tumour incidence and their increased sensitivity
towards the lymphomagen ethylnitrosourea these mice may present an
interesting model for short-term carcinogenicity testing. Here, we report
on the further exploration of this transgenic mouse model with two
additional carcinogens known to have, among others, the
lymphohaematopoietic system as target, i.e. benzo[a]pyrene (B[a]P) and
12-O-tetradecanoylphorbol-13-acetate (TPA). B[a]P, given three times a week
(by gavage) for 13 weeks at 4.3, 13 or 39 mg/kg body weight, resulted in a
dose-related increase in lymphomas up to a 90% incidence in E(mu)-pim-1
mice during the observation period of 40 weeks. B[a]P also induced tumours
of the forestomach within this observation period, though at a lower
incidence and apparently equally effective in wildtype and transgenic mice.
TPA, on the other hand, was unable to induce lymphomas (or tumours in any
other organ) in either transgenic or wildtype animals within the
observation period of 44 weeks, when applied dermally at the maximum
tolerated dose of 3 microg/mouse, twice a week for 35 weeks. Molecular
analysis showed that B[a]P-induced lymphomas in transgenic mice were of
T-cell origin, 80% of which had elevated levels of c-myc expression. None
of the lymphomas had increased N-myc expression and mutation analysis of
the ras-gene family revealed a K-ras mutation in only one out of eight
tumours investigated. Also, none of the lymphomas showed aberrant
expression of p53 as determined by immunohistochemistry. It is concluded
that the E mu-pim-1 mouse model will not be very suitable for short-term
carcinogenicity testing in general: only genotoxic chemicals that have the
lymphohaematopoietic system as target for carcinogenesis in wild- type
mice, appear to be efficiently identified.
相似文献
139.
Metabolism of glycine in the nonketotic form of hyperglycinemia 总被引:2,自引:0,他引:2
140.
Goldschmidt-Clermont PJ Coleman LD Pham YM Cooke GE Shear WS Weiss EJ Kral BG Moy TF Yook RM Blumenthal RS Becker DM Becker LC Bray PF 《Archives of pathology & laboratory medicine》1999,123(12):1223-1229
BACKGROUND: The Pl(A2) polymorphism of GPIIIa has been associated with unstable coronary syndromes in some studies, but the association has remained debated. None of the previous studies have focused on families at high risk. Risk factors tend to cluster within kindreds with high prevalence of premature coronary heart disease (CHD). Therefore, a heightened prevalence of the Pl(A2) polymorphism among siblings of patients with CHD would support the hypothesis that Pl(A2) is linked, directly or indirectly, to CHD. OBJECTIVES: To measure the prevalence of the Pl(A2) polymorphism among siblings of patients with CHD before the age of 60 years and to seek an association between the Pl(A2) polymorphism and established atherosclerotic and thrombogenic risk factors. METHODS: From January 1994 to April 1996, we genotyped 116 asymptomatic siblings (60 Caucasians, 56 Afro-Caribbeans) of patients with CHD manifestations before the age of 60 years for the Pl(A) polymorphism (also called HPA-1). A control cohort was used for comparison, consisting of individuals that were matched for race and geographic area but were free of CHD (n = 268, 168 Caucasians and 100 Afro-Caribbeans). In addition, we have characterized the sibling cohort for other atherogenic and thrombogenic risk factors. RESULTS: The prevalence of Pl(A2)-positive individuals (Pl(A2)[+], Pl(A1/A2) heterozygotes plus Pl(A2/A2) homozygotes) in the sibling cohort was high: 41.4%. When analyzed separately, the prevalence of Pl(A2)(+) siblings was 53.3% among Caucasians and 28.6% among Afro-Caribbeans. There was no association between Pl(A2) and other established atherogenic or thrombogenic risk factors. Interestingly, the clustering of other risk factors was lesser among Pl(A2)(+) siblings than their Pl(A1) counterparts. CONCLUSIONS: This study supports the hypothesis that the prevalence of Pl(A2)(+) individuals is high in kindreds with premature CHD. Hence, like the established risk factors that tend to cluster in families with premature CHD and contribute strongly to the accelerated atherosclerotic process affecting these individuals, the Pl(A2) polymorphism of GPIIIa may represent an inherited risk that promotes the thromboembolic complications of CHD. That these asymptomatic Pl(A2)(+) siblings had overall less established risk factors than their Pl(A1) counterparts might represent an explanation for why they remained asymptomatic despite their Pl(A2) positivity. 相似文献